Mondrian Investment Partners LTD Abb Vie Inc. Transaction History

Mondrian Investment Partners LTD

$6.01 Billion
Q3 2024

A detailed history of Mondrian Investment Partners LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Mondrian Investment Partners LTD holds 644,285 shares of ABBV stock, worth $113 Million. This represents 2.12% of its overall portfolio holdings.

Number of Shares

644,285

Previous 843,897 23.65%

Holding current value

$113 Million

Previous $145 Million 12.1%

% of portfolio

2.12%

Previous 2.51%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$163.84 - $199.33 $32.7 Million - $39.8 Million	-199,612 Reduced 23.65%	644,285 $127 Million
Q2 2024 Aug 12, 2024	SELL	$154.79 - $180.76 $11.1 Million - $13 Million	-72,006 Reduced 7.86%	843,897 $145 Million
Q1 2024 May 07, 2024	SELL	$159.82 - $182.1 $8.3 Million - $9.45 Million	-51,920 Reduced 5.36%	915,903 $167 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $1.69 Million - $1.9 Million	12,287 Added 1.29%	967,823 $150 Million
Q3 2023 Nov 06, 2023	SELL	$133.59 - $154.65 $17.7 Million - $20.5 Million	-132,802 Reduced 12.2%	955,536 $142 Million
Q2 2023 Sep 20, 2023	BUY	$132.51 - $164.9 $20.8 Million - $25.9 Million	157,027 Added 16.86%	1,088,338 $147 Million
Q1 2023 Sep 20, 2023	SELL	$144.61 - $166.54 $22.7 Million - $26.2 Million	-157,027 Reduced 14.43%	931,311 $148 Million
Q1 2023 May 09, 2023	BUY	$144.61 - $166.54 $10.2 Million - $11.8 Million	70,741 Added 8.22%	931,311 $148 Million
Q4 2022 Feb 03, 2023	SELL	$138.31 - $165.87 $26.4 Million - $31.7 Million	-190,962 Reduced 18.16%	860,570 $139 Million
Q3 2022 Oct 21, 2022	BUY	$134.21 - $153.93 $2.43 Million - $2.79 Million	18,126 Added 1.75%	1,051,532 $141 Million
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $14.1 Million - $17.9 Million	102,154 Added 10.97%	1,033,406 $158 Million
Q1 2022 May 05, 2022	SELL	$131.98 - $163.75 $21 Million - $26.1 Million	-159,274 Reduced 14.61%	931,252 $151 Million
Q4 2021 Feb 09, 2022	BUY	$107.43 - $135.93 $60.2 Million - $76.2 Million	560,488 Added 105.74%	1,090,526 $148 Million
Q3 2021 Oct 27, 2021	BUY	$106.4 - $120.78 $7.86 Million - $8.92 Million	73,841 Added 16.19%	530,038 $57.2 Million
Q2 2021 Jul 30, 2021	BUY	$105.21 - $117.21 $8.48 Million - $9.45 Million	80,593 Added 21.46%	456,197 $51.4 Million
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $6.25 Million - $6.88 Million	61,129 Added 19.44%	375,604 $41.9 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $8.37 Million - $11.3 Million	104,023 Added 49.43%	314,475 $33.7 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $7.69 Million - $9.03 Million	-89,564 Reduced 29.85%	210,452 $17.9 Million
Q2 2020 Aug 10, 2020	BUY	$73.37 - $98.18 $22 Million - $29.5 Million	300,016 New	300,016 $29.5 Million

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mondrian Investment Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Mondrian Investment Partners LTD with notifications on news.

Account

Mondrian Investment Partners LTD Abb Vie Inc. Transaction History